Feb 19 (Reuters) - Cassava Sciences said on Thursday the U.S. Department of Justice had ended its probe into the company ...

Procurement Sciences, the end-to-end AI growth platform for government contractors, announced the acquisition of Rogue AI, an ...

More than 1,500 potential weapons were detected by scanners at the doors of Manitoba's biggest hospital over an eight-month ...

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best immunotherapy stocks to buy according to hedge funds. Gilead Sciences, Inc. (NASDAQ:GILD) announced its fiscal Q4 and full year 2025 results on ...

Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to ...

The company cooperated wholly with the DOJ’s probe, Cassava said. ・Cassava Sciences is now developing Simufilam to treat tuberous sclerosis complex (TSC)-related epilepsy after dropping its ...

For Central Ohio—a region experiencing significant population growth, large scale healthcare system expansions, and increased ...

该调查涉及United States v. Wang案中描述的指控,该案已于2025年10月23日被司法部驳回并附带偏见。此次结案是在该公司于2024年9月与美国证券交易委员会达成和解之后,当时Cassava因基于过失的披露指控支付了罚款,但未承认或否认相关指控。

The cancer-fighting drug manufacturing facility will create 500 new manufacturing jobs and 4,000 construction jobs.

As AI rapidly evolves, the School of Computing will allow the University of Texas to more deeply explore artificial ...

A team of researchers has found a way to steer the output of large language models by manipulating specific concepts inside ...

The report by KPMG in India and UnearthIQ highlighted how pharma and life sciences GCCs are leveraging AI to bring in measurable gains and lower drug development time.